Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
Open-market buys, last 90 days
$74,198
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$74,198. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-10-08 BROADWOOD PARTNERS LP Director Other acquisition +4,040,523 $3.12 $12.6M 17,832,785
2014-10-08 BROADWOOD PARTNERS LP Director Other acquisition +0 17,832,785
2014-07-22 BROADWOOD PARTNERS LP Director Purchase +100,000 $2.65 $265K 13,522,262
2014-07-22 BROADWOOD PARTNERS LP Director Purchase +0 13,522,262
2014-07-22 BROADWOOD PARTNERS LP Director Purchase +270,000 $2.65 $716K 13,792,262
2014-07-22 BROADWOOD PARTNERS LP Director Purchase +0 13,792,262
2014-07-22 Peabody Robert Sr. VP, COO, and CFO Sale −100,000 $2.65 $265K 315,777
2014-07-22 WEST MICHAEL D Chief Executive Officer Sale −270,000 $2.65 $716K 875,987
2014-07-21 Peabody Robert Sr. VP, COO, and CFO Exercise or conversion +475,000 $0.50 $238K 505,400
2014-07-21 Peabody Robert Sr. VP, COO, and CFO Shares withheld for taxes −89,623 $2.65 $238K 415,777
2014-07-21 Peabody Robert Sr. VP, COO, and CFO Exercise or conversion · Option to Purchase Common Shares −475,000 0
2014-07-21 WEST MICHAEL D Chief Executive Officer Exercise or conversion +1,470,400 $0.50 $735K 1,580,000
2014-07-21 WEST MICHAEL D Chief Executive Officer Shares withheld for taxes −434,013 $2.65 $1.2M 1,145,987
2014-07-21 WEST MICHAEL D Chief Executive Officer Exercise or conversion · Option to Purchase Common Shares −1,470,400 0
2014-07-01 SCHLACHET DAVID Director Grant or award · Option to Purchase Common Shares +20,000 20,000
2014-07-01 SCHLACHET DAVID Director Grant or award · Option to Purchase Common Shares +20,000 20,000
2014-07-01 LICHTINGER PEDRO Director Grant or award · option to Purchase Common Shares +20,000 20,000
2014-07-01 KINGSLEY ALFRED D Director Grant or award · Option to Purchase Common Shares +50,000 50,000
2014-07-01 FARRELL STEPHEN C Director Grant or award · Option to Purchase Common Shares +20,000 20,000
2014-07-01 ANDREWS DEBORAH J Director Grant or award · Option to Purchase Common Shares +20,000 20,000

Page 20 of 24 · 472 trades